Daiichi Sankyo to pay $39M to settle DOJ claims it paid kickbacks to docs

Japanese drugmaker Daiichi Sankyo will pay $39 million to state and federal health programs, and a whistleblower, to settle claims it paid doctors kickbacks to prescribe some of its drugs, Reuters reports. The settlement, the Justice Department said, stemmed from a whistleblower lawsuit filed by former Daiichi sales representative Kathy Fragoules. She will get $6.1 million of the settlement. The drugmaker was accused of enticing doctors with speaking fees and lavish dinners, sometimes to speak only to their own staffs, the government contended. Story

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.